BioMarin Pharmaceutical Inc.
Biotechnology
See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
Who We Are
BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.
Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.
Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.
About Corporate Groups
It takes a village, and at BioMarin, our general and admin teams are the village behind our success. From the IT experts who manage our technology to the human resources professionals who hire the people who make it all possible, these teams support our organization and span all areas of operations.
SUMMARY
We are seeking a highly motivated Accounting Manager, Global Revenue to join our Global Revenue Accounting Team. The successful candidate will play a key role in ensuring the accuracy and integrity of revenue accounting, gross-to-net accounting, financial reporting, and related internal controls. This role will manage month- and quarter-end revenue close activities, contract review, rebate and deduction processes, support OTC accounting operations, and revenue-related reporting under US GAAP and ASC 606. The Manager will also support integration activities, which would include the alignment of revenue accounting and OTC processes, systems, data, controls, reporting requirements, and transition to steady-state operations. This position will partner cross-functionally with Commercial, Legal, Market Access, Finance, IT/DTA, Treasury, Tax, and external auditors. The role requires strong technical accounting knowledge, process leadership, analytical skills, communication capabilities, and the ability to drive execution in a fast-paced, evolving environment.
KEY RESPONSIBILITIES
EXPERIENCE/REQUIREMENTS/SKILLS:
EDUCATION/CERTIFICATION
Workstyle:
Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.
Equal Opportunity Employer/Veterans/Disabled
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
Ireland Safety Responsibility
Support the organisation’s commitment to environmental protection, injury prevention, and continual improvement of EHS management systems. Actively contribute to a safe and environmentally responsible workplace by identifying hazards, reporting incidents and participating in EHS initiatives and training.
After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.
Marcus Rivera
Chief Revenue Officer

Best Western Hotels & Resorts

Overjet

Algolia

The Joule

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.